The International Waldenstrom’s Macroglobulinemia Foundation ((IWMF) is a patient-founded and patient-led international nonprofit organization with a simple but compelling vision and mission.
OUR VISION: A world without WM (Waldenstrom’s macroglobulinemia)
OUR MISSION: Support and educate everyone affected by Waldenstrom’s macroglobulinemia (WM) while advancing the search for a cure
The IWMF is committed to creating a world without WM by finding a cure. Since 1999, the IWMF has invested over $18 million in WM research projects throughout the world. Thanks to this research WM patients have better treatment options that can lead to deeper, longer lasting remissions, and fewer side effects.
October 21, 2022
September 22, 2021
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
September 10, 2015
Emil Parente is a WMer with a real past, and he is happy to share it with others, particularly those who are newly diagnosed.
September 04, 2015
Marguerite Regan tells her WaldenstrÃ¶m's macroglobulinemia story.